Brief: RVL Pharmaceuticals Files Prospectus Relates To Resale/Other Disposition From Time To Time Of Up To 15.5 Million Ordinary Shares By Selling Shareholders
19/08/2022 21:54
Aug 19 (Reuters) - RVL Pharmaceuticals PLC RVLP.O :
* RVL PHARMACEUTICALS FILES PROSPECTUS RELATES TO
RESALE/OTHER
DISPOSITION FROM TIME TO TIME OF UP TO 15.5 MILLION ORDINARY
SHARES BY SELLING SHAREHOLDERS
Source text for Eikon: [https://bit.ly/3AzgFTx]
Further company coverage: RVLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius